Name | S0859 |
Synonyms | S0859 100852 S 0859 CS-1766 S 0859 S-0859 (4S)-4-HYDROXY-4-[(3R)-3-HYDROXYBUTYL]-3,5,5-TRIMETHYL-2-CYCLOHEXEN-1-ONE 2-Chloro-N-((2'-(N-cyanosulfamoyl)-[1,1'-biphenyl]-4-yl)methyl)-N-(4-methylbenzyl)benzamide 2-Chloro-N-[[2′-[(cyanoamino)sulfonyl][1,1′-biphenyl]-4-yl]methyl]-N-[(4-methylphenyl)methyl]-benzamide 2-chloro-N-[[2'-[(cyanoamino)sulfonyl][1,1'-biphenyl]-4-yl]methyl]-N-[(4-methylphenyl)methyl]- S0859 |
CAS | 1019331-10-2 |
Molecular Formula | C29H24ClN3O3S |
Molar Mass | 530.04 |
Solubility | DMSO: soluble10mg/mL, clear |
Appearance | powder |
Color | white to light brown |
Storage Condition | 2-8°C |
In vitro study | Treatment with NBC inhibitor S0859 significantly increased caspase-3 activity and elevated the number of apoptotic EC. S0859 is potentially important for probing the transporter's functional role in heart and other tissues. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.887 ml | 9.433 ml | 18.867 ml |
5 mM | 0.377 ml | 1.887 ml | 3.773 ml |
10 mM | 0.189 ml | 0.943 ml | 1.887 ml |
5 mM | 0.038 ml | 0.189 ml | 0.377 ml |